At 5.6% CAGR Market snapshot on Veterinary Drugs Market 2019-2025

By admin On September 6, 2019 In Business Tagged AP, Business, Comtex, MRV, Reuters, us50 Wire 4, Wire 1, Wire 2, Wire 3

Veterinary Drugs Market by top manufacturers, type and application, with sales market share and growth rate Forecasts till 2025

Pune, India – September 6, 2019 /MarketersMedia/ —

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the Global Market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Rise in Intake of Meat Consumption to Propel Market
The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

The Asia Pacific to Exhibit Fastest Growth Rate
The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.
On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

Some major points from Table of Content:
……………………
7. Europe Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
7.1. Key Findings / Summary
7.2. Market Analysis – By Product
7.2.1 Anti-infectives
7.2.2 Anti-inflammatory
7.2.3 Parasiticides
7.2.4 Others
7.3. Market Analysis – By Animal
7.3.1 Companion
7.3.2 Livestock
7.4. Market Analysis – By Route of Administration
7.4.1 Oral
7.4.2 Parenteral
7.4.3 Topical
7.5. Market Analysis – By Distribution Channel
7.5.1 Veterinary Hospitals
7.5.2 Veterinary Clinics
7.5.3 Pharmacies & Drug Stores
7.5.4 Others
7.6. Market Analysis – By Country/ Sub-region
7.6.1 U.K.
7.6.2 Germany
7.6.3 France
7.6.4 Italy
7.6.5 Spain
7.6.6 Scandinavia
7.6.7 Rest of Europe
8. Asia Pacific Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
8.1. Key Findings / Summary
8.2. Market Analysis – By Product
8.2.1 Anti-infectives
8.2.2 Anti-inflammatory
8.2.3 Parasiticides
8.2.4 Others
8.3. Market Analysis – By Animal
8.3.1 Companion
8.3.2 Livestock
8.4. Market Analysis – By Route of Administration
8.4.1 Oral
8.4.2 Parenteral
8.4.3 Topical
8.5. Market Analysis – By Distribution Channel
8.5.1 Veterinary Hospitals
8.5.2 Veterinary Clinics
8.5.3 Pharmacies & Drug Stores
8.5.4 Others
8.6. Market Analysis – By Country/ Sub-region
8.6.1 Japan
8.6.2 China
8.6.3 India
8.6.4 Australia
8.6.5 Southeast Asia
8.6.6 Rest of Asia Pacific
9. Latin America Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
9.1. Key Findings / Summary
9.2. Market Analysis – By Product
9.2.1 Anti-infectives
9.2.2 Anti-inflammatory
9.2.3 Parasiticides
9.2.4 Others
9.3. Market Analysis – By Animal
9.3.1 Companion
9.3.2 Livestock
9.4. Market Analysis – By Route of Administration
9.4.1 Oral
9.4.2 Parenteral
9.4.3 Topical
9.5. Market Analysis – By Distribution Channel
9.5.1 Veterinary Hospitals
9.5.2 Veterinary Clinics
9.5.3 Pharmacies & Drug Stores
9.5.4 Others
9.6. Market Analysis – By Country/Sub-region
9.6.1 Brazil
9.6.2 Mexico
9.6.3 Rest of Latin America
10. Middle East & Africa Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
10.1. Key Findings / Summary
10.2. Market Analysis – By Product
10.2.1 Anti-infectives
10.2.2 Anti-inflammatory
10.2.3 Parasiticides
10.2.4 Others
10.3. Market Analysis – By Animal
10.3.1 Companion
10.3.2 Livestock
10.4. Market Analysis – By Route of Administration
10.4.1 Oral
10.4.2 Parenteral
10.4.3 Topical
10.5. Market Analysis – By Distribution Channel
10.5.1 Veterinary Hospitals
10.5.2 Veterinary Clinics
10.5.3 Pharmacies & Drug Stores
10.5.4 Others
10.6. Market Analysis – By Country
10.6.1 South Africa
10.6.2 GCC Countries
10.6.3 Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2017)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1 Zoetis
11.5.2 Intervet Inc.
11.5.3 Boehringer Ingelheim International GmbH
11.5.4 Ceva
11.5.5 Elanco
11.5.6 Vetoquinol S.A.
11.5.7 Bayer AG
11.5.8 Other Prominent Players
12. Strategic Recommendations
Continued…